rowid,run.accession,experiment.accession,sample.accession,study.accession,bioproject,study.title,study.alias,study.type,study.abstract,study.attributes,study.PMIDs,sample.description,sample.title,sample.alias,sample.centername,sample.attributes,GEOsample.title,GEOsample.dataprocessing,GEOsample.source,GEOsample.treatmentprotocol,GEOsample.extractprotocol,GEOsample.growthprotocol,GEOsample.characteristics,GEOsample.accession,experiment.title,experiment.alias,experiment.library_name,experiment.design_description,experiment.library_construction_protocol,experiment.attributes,experiment.library_strategy,experiment.library_source,experiment.library_selection,experiment.library_layout,experiment.platform,experiment.instrument_model,experiment.spot_descriptor,experiment.study_ref,run.title,run.attributes,run.filename,run.semantic_name,run.total_bases,run.total_spots,run.alias,run.read_lengths,run.base_counts,run.r1_length,run.r2_length,run.r3_length,run.r4_length,run.Acount,run.Ccount,run.Gcount,run.Tcount,run.Ncount,run.experiment,run.pool_member,submission.accession,submission.srasource,submission.bioprojectsource,seqdetective.n_mates,seqdetective.mapping_rate.mate1,seqdetective.mapping_rate.mate2,seqdetective.nofeature_rate.mate1,seqdetective.nofeature_rate.mate2,seqdetective.sparsity.mate1,seqdetective.sparsity.mate2,seqdetective.pos_strand_rate.mate1,seqdetective.pos_strand_rate.mate2,seqdetective.readlen.mate1,seqdetective.readlen.mate2,seqdetective.judgement.mate1,seqdetective.judgement.mate2,seqdetective.judgement.reason,platform_family,instrument_generation,read_bias,selection_class,prep_kit,sc_or_bulk,tech_class,technology,tech_variant,submission.bioprojectsource.country,earliest_date,devstage_curation,devstage_curation_coarse,tissue_curation,tissue_curation_coarse 10161,ERR5385019,ERX5169945,ERS5845164,ERP127328,PRJEB43370,RNA seq of whole zebrafish embryos at 6 and 10hpf,E-MTAB-10167,Other,RNA seq was performed to reveal the RNA expression profile at two different stages shield and tail bud stage in the embryogenesis of zebrafish wild type strain AB. Zebrafish embryos were collected at the shield stage and tail bud stage which correspond to 6 hpf and 10 hpf respectively. Total RNA was extracted with miRNeasy Mini Kit libraries for sequencing were prepared with TruSeq stranded mRNA library prep kit Illumina and paired end sequencing was performed using NovaSeq 6000 Illumina.,ENA FIRST PUBLIC:2022 01 14|ENA LAST UPDATE:2022 01 14,,Protocols: Zebrafish embryos obtained from wild type strain AB were collected at the shield stage and tail bud stage which correspond to 6 hpf and 10 hpf respectively. Total RNA was extracted with miRNeasy Mini Kit Qiagen 217004 according to the manufacturer's instructions. Quality of extracted RNA was assessed using the NanoDrop ND 1000 Spectrophotometer ThermoFisher Scientific and by agarose gel electrophoresis. Samples were stored at 80 ℃ Libraries for sequencing were prepared with TruSeq stranded mRNA library prep kit Illumina according to the manufacturer's instructions.,Danio rerio AB wildtype tail bud stage,SAMEA8158396,"Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University",ENA first public:2021 07 01|ENA last update:2021 07 01|External Id:SAMEA8158396|INSDC center alias:Department of Cellular Regulation Research Institute for Microbial Diseases Osaka University|INSDC center name:Department of Cellular Regulation Research Institute for Microbial Diseases Osaka University|INSDC first public:2021 07 01T00:11:10Z|INSDC last update:2021 07 01T00:11:10Z|INSDC status:public|Submitter Id:E MTAB 10167:Danio rerio AB wildtype tail bud stage|age:10|broker name:ArrayExpress|common name:zebrafish|developmental stage:gastrula bud|genotype:wild type genotype|organism part:whole organism|sample name:E MTAB 10167:Danio rerio AB wildtype tail bud stage|strain:AB,,,,,,,,,Illumina NovaSeq 6000 paired end sequencing; RNA seq of whole zebrafish embryos at 6 and 10hpf,E MTAB 10167:Danio rerio AB wildtype tail bud stage p,Danio rerio AB wildtype tail bud stage p,RNA seq of whole zebrafish embryos at 6 and 10hpf,Zebrafish embryos obtained from wild type strain AB were collected at the shield stage and tail bud stage which correspond to 6 hpf and 10 hpf respectively. Total RNA was extracted with miRNeasy Mini Kit Qiagen 217004 according to the manufacturer's instructions. Quality of extracted RNA was assessed using the NanoDrop ND 1000 Spectrophotometer ThermoFisher Scientific and by agarose gel electrophoresis. Samples were stored at 80 ℃ Libraries for sequencing were prepared with TruSeq stranded mRNA library prep kit Illumina according to the manufacturer's instructions.,Experimental Factor: developmental stage:gastrula bud,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,ERP127328,Illumina NovaSeq 6000 paired end sequencing; RNA seq of whole zebrafish embryos at 6 and 10hpf,ENA FIRST PUBLIC:2022 01 14|ENA LAST UPDATE:2022 01 14,10hpf_Zebrafish_R1.fastq.gz 10hpf_Zebrafish_R2.fastq.gz,fastq fastq,16339887666.0,80890533.0,E MTAB 10167:10hpf Zebrafish R,0:101 1:101,A:4335047391;C:3850067296;G:3827279083;T:4327089161;N:404735,101,101,,,4335047391,3850067296,3827279083,4327089161,404735,ERX5169945,ERS5845164,ERA3502311,"Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University|European Nucleotide Archive","Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University|European Nucleotide Archive",2,0.95781,0.95944,0.09186,0.09149,0.73608,0.73677,0.47851,0.48067,101,101,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,trueseq,bulk,unknown,unknown,,Japan,2021-07-01,Gastrula,Embryo,Whole Organism,All anatomical structures 10162,ERR5385018,ERX5169944,ERS5845163,ERP127328,PRJEB43370,RNA seq of whole zebrafish embryos at 6 and 10hpf,E-MTAB-10167,Other,RNA seq was performed to reveal the RNA expression profile at two different stages shield and tail bud stage in the embryogenesis of zebrafish wild type strain AB. Zebrafish embryos were collected at the shield stage and tail bud stage which correspond to 6 hpf and 10 hpf respectively. Total RNA was extracted with miRNeasy Mini Kit libraries for sequencing were prepared with TruSeq stranded mRNA library prep kit Illumina and paired end sequencing was performed using NovaSeq 6000 Illumina.,ENA FIRST PUBLIC:2022 01 14|ENA LAST UPDATE:2022 01 14,,Protocols: Zebrafish embryos obtained from wild type strain AB were collected at the shield stage and tail bud stage which correspond to 6 hpf and 10 hpf respectively. Total RNA was extracted with miRNeasy Mini Kit Qiagen 217004 according to the manufacturer's instructions. Quality of extracted RNA was assessed using the NanoDrop ND 1000 Spectrophotometer ThermoFisher Scientific and by agarose gel electrophoresis. Samples were stored at 80 ℃ Libraries for sequencing were prepared with TruSeq stranded mRNA library prep kit Illumina according to the manufacturer's instructions.,Danio rerio AB wildtype shield stage,SAMEA8158395,"Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University",ENA first public:2021 07 01|ENA last update:2021 07 01|External Id:SAMEA8158395|INSDC center alias:Department of Cellular Regulation Research Institute for Microbial Diseases Osaka University|INSDC center name:Department of Cellular Regulation Research Institute for Microbial Diseases Osaka University|INSDC first public:2021 07 01T00:11:10Z|INSDC last update:2021 07 01T00:11:10Z|INSDC status:public|Submitter Id:E MTAB 10167:Danio rerio AB wildtype shield stage|age:6|broker name:ArrayExpress|common name:zebrafish|developmental stage:gastrula shield|genotype:wild type genotype|organism part:whole organism|sample name:E MTAB 10167:Danio rerio AB wildtype shield stage|strain:AB,,,,,,,,,Illumina NovaSeq 6000 paired end sequencing; RNA seq of whole zebrafish embryos at 6 and 10hpf,E MTAB 10167:Danio rerio AB wildtype shield stage p,Danio rerio AB wildtype shield stage p,RNA seq of whole zebrafish embryos at 6 and 10hpf,Zebrafish embryos obtained from wild type strain AB were collected at the shield stage and tail bud stage which correspond to 6 hpf and 10 hpf respectively. Total RNA was extracted with miRNeasy Mini Kit Qiagen 217004 according to the manufacturer's instructions. Quality of extracted RNA was assessed using the NanoDrop ND 1000 Spectrophotometer ThermoFisher Scientific and by agarose gel electrophoresis. Samples were stored at 80 ℃ Libraries for sequencing were prepared with TruSeq stranded mRNA library prep kit Illumina according to the manufacturer's instructions.,Experimental Factor: developmental stage:gastrula shield,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,ERP127328,Illumina NovaSeq 6000 paired end sequencing; RNA seq of whole zebrafish embryos at 6 and 10hpf,ENA FIRST PUBLIC:2022 01 14|ENA LAST UPDATE:2022 01 14,6hpf_Zebrafish_R1.fastq.gz 6hpf_Zebrafish_R2.fastq.gz,fastq fastq,13564619564.0,67151582.0,E MTAB 10167:6hpf Zebrafish R,0:101 1:101,A:3600635755;C:3192954183;G:3191087455;T:3579609049;N:333122,101,101,,,3600635755,3192954183,3191087455,3579609049,333122,ERX5169944,ERS5845163,ERA3502311,"Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University|European Nucleotide Archive","Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University|European Nucleotide Archive",2,0.95783,0.95972,0.08032,0.07998,0.75619,0.75694,0.468,0.48015,101,101,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,trueseq,bulk,unknown,unknown,,Japan,2021-07-01,Gastrula,Embryo,Whole Organism,All anatomical structures 25316,SRR25786849,SRX21509238,SRS18740266,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes miR 144 mutant Danio rerio 3 dpf,CD KD 144,,strain:mir 144 mutant|age:3 days|collection date:not provided|geo loc name:not provided|sex:mixed|tissue:whole embryo|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq Erythrocytes miR 144 mutant Danio rerio 3 dpf replicate 2,CD KD 1442,CD KD 1442,Libraries were made using Illumina mRNA seq library prep kit,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,NextSeq 2000,,SRP457465,,,CD_KD_1442-R_S4_L001_R2_001.fastq.gz CD_KD_1442-R_S4_L001_R1_001.fastq.gz,fastq fastq,15176751228.0,77119924.0,CD KD 1442 R S4 L001 R1 001.fastq.gz,0:98.43 1:98.37,A:3779746373;C:3784109407;G:3856858311;T:3696705097;N:59332040,98,98,,,3779746373,3784109407,3856858311,3696705097,59332040,SRX21509238,SRS18740266,SRA1701488,University of East Anglia|Biological Sciences,University of East Anglia,2,0.97046,0.97577,0.04054,0.04056,0.84404,0.84368,0.44473,0.44497,99,100,B,B,biological fallback assumption,illumina,nextseq_v2,unknown,poly_a,unknown,bulk,unknown,unknown,,United Kingdom,2023-08-30,Larval,Larval,Whole Organism,All anatomical structures 25317,SRR25786850,SRX21509237,SRS18740266,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes miR 144 mutant Danio rerio 3 dpf,CD KD 144,,strain:mir 144 mutant|age:3 days|collection date:not provided|geo loc name:not provided|sex:mixed|tissue:whole embryo|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq Erythrocytes miR 144 mutant Danio rerio 3 dpf replicate 1,CD KD 1441,CD KD 1441,Libraries were made using Illumina mRNA seq library prep kit,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,NextSeq 2000,,SRP457465,,,CD_KD_1441-R_S3_L001_R2_001.fastq.gz CD_KD_1441-R_S3_L001_R1_001.fastq.gz,fastq fastq,12981589931.0,66199400.0,CD KD 1441 R S3 L001 R1 001.fastq.gz,0:98.08 1:98.02,A:3222063377;C:3237477192;G:3298955148;T:3151608365;N:71485849,98,98,,,3222063377,3237477192,3298955148,3151608365,71485849,SRX21509237,SRS18740266,SRA1701488,University of East Anglia|Biological Sciences,University of East Anglia,2,0.97163,0.97711,0.03644,0.03649,0.8188,0.81889,0.44686,0.44149,100,101,B,B,biological fallback assumption,illumina,nextseq_v2,unknown,poly_a,unknown,bulk,unknown,unknown,,United Kingdom,2023-08-30,Larval,Larval,Whole Organism,All anatomical structures 25318,SRR25786851,SRX21509236,SRS18740265,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes Wild type Danio rerio 3 dpf,CD KD WT,,strain:Wildtype|age:3 days|collection date:not provided|geo loc name:not provided|sex:mixed|tissue:whole embryo|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq Erythrocytes Wild type Danio rerio 3 dpf replicate 2,CD KD WT2,CD KD WT2,Libraries were made using Illumina mRNA seq library prep kit,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,NextSeq 2000,,SRP457465,,,CD_KD_WT2-R_S2_L001_R1_001.fastq.gz CD_KD_WT2-R_S2_L001_R2_001.fastq.gz,fastq fastq,13841850598.0,71086657.0,CD KD WT2 R S2 L001 R1 001.fastq.gz,0:97.39 1:97.33,A:3429992533;C:3433873133;G:3489428993;T:3365505686;N:123050253,97,97,,,3429992533,3433873133,3489428993,3365505686,123050253,SRX21509236,SRS18740265,SRA1701488,University of East Anglia|Biological Sciences,University of East Anglia,2,0.97088,0.97596,0.03787,0.0381,0.84896,0.8496,0.45727,0.45346,101,101,B,B,biological fallback assumption,illumina,nextseq_v2,unknown,poly_a,unknown,bulk,unknown,unknown,,United Kingdom,2023-08-30,Larval,Larval,Whole Organism,All anatomical structures 25319,SRR25786852,SRX21509235,SRS18740265,SRP457465,PRJNA1010662,The miR 144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.,PRJNA1010662,Other,Differentiation of stem and progenitor cells is a highly regulated process that involves the coordinated action of multiple layers of regulation. Here we show how the post transcriptional regulatory layer instructs the chromatin regulation level via miR 144 and its targets to orchestrate chromatin condensation during erythropoiesis. The loss of miR 144 leads to impaired chromatin condensation during erythrocyte maturation.,,,,RNA seq Erythrocytes Wild type Danio rerio 3 dpf,CD KD WT,,strain:Wildtype|age:3 days|collection date:not provided|geo loc name:not provided|sex:mixed|tissue:whole embryo|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq Erythrocytes Wild type Danio rerio 3 dpf replicate 1,CD KD WT1,CD KD WT1,Libraries were made using Illumina mRNA seq library prep kit,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,NextSeq 2000,,SRP457465,,,CD_KD_WT1-R_S1_L001_R1_001.fastq.gz CD_KD_WT1-R_S1_L001_R2_001.fastq.gz,fastq fastq,13279321095.0,67105432.0,CD KD WT1 R S1 L001 R1 001.fastq.gz,0:98.98 1:98.91,A:3310018513;C:3313506420;G:3374819099;T:3243710775;N:37266288,98,98,,,3310018513,3313506420,3374819099,3243710775,37266288,SRX21509235,SRS18740265,SRA1701488,University of East Anglia|Biological Sciences,University of East Anglia,2,0.97038,0.97604,0.04235,0.04238,0.83676,0.8367,0.45607,0.45443,101,101,B,B,biological fallback assumption,illumina,nextseq_v2,unknown,poly_a,unknown,bulk,unknown,unknown,,United Kingdom,2023-08-30,Larval,Larval,Whole Organism,All anatomical structures 29718,SRR27485663,SRX23156886,SRS20107307,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,4 cell R3,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:1 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:3|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 1 hpf rep4,EV06010,EV06010,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06010.R1.fastq.gz,fastq,620142356.0,8227837.0,EV06010.R1.fastq.gz,0:75.37,A:186029536;C:118842640;G:134072972;T:181171903;N:25305,75,,,,186029536,118842640,134072972,181171903,25305,SRX23156886,SRS20107307,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.90656,,0.06918,,0.80192,,0.72472,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Cleavage,Embryo,Whole Organism,All anatomical structures 29721,SRR27485666,SRX23156883,SRS20107304,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,24h R2,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:24 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:2|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 24 hpf rep4,EV06007,EV06007,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06007.R1.fastq.gz,fastq,758984715.0,10062029.0,EV06007.R1.fastq.gz,0:75.43,A:221215464;C:148997667;G:167225079;T:221520231;N:26274,75,,,,221215464,148997667,167225079,221520231,26274,SRX23156883,SRS20107304,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.90914,,0.18457,,0.77782,,0.38818,,75,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Pharyngula,Embryo,Whole Organism,All anatomical structures 29722,SRR27485667,SRX23156882,SRS20107303,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,Bud R2,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:10 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:2|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 10 hpf rep4,EV06006,EV06006,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06006.R1.fastq.gz,fastq,734373761.0,9740919.0,EV06006.R1.fastq.gz,0:75.39,A:217249501;C:141011173;G:161749180;T:214341396;N:22511,75,,,,217249501,141011173,161749180,214341396,22511,SRX23156882,SRS20107303,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.902,,0.14583,,0.80937,,0.67478,,75,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Gastrula,Embryo,Whole Organism,All anatomical structures 29723,SRR27485668,SRX23156881,SRS20107302,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,Dome R2,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:5 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:2|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 5 hpf rep4,EV06005,EV06005,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06005.R1.fastq.gz,fastq,776568876.0,10317721.0,EV06005.R1.fastq.gz,0:75.27,A:238745211;C:151859247;G:171793387;T:214113382;N:57649,75,,,,238745211,151859247,171793387,214113382,57649,SRX23156881,SRS20107302,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.87227,,0.14085,,0.81797,,0.72906,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Blastula,Embryo,Whole Organism,All anatomical structures 29724,SRR27485669,SRX23156880,SRS20107301,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,1K cell R2,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:3 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:2|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 3 hpf rep4,EV06004,EV06004,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06004.R1.fastq.gz,fastq,682509965.0,9050328.0,EV06004.R1.fastq.gz,0:75.41,A:196111480;C:138950038;G:156032208;T:191368964;N:47275,75,,,,196111480,138950038,156032208,191368964,47275,SRX23156880,SRS20107301,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.91494,,0.12926,,0.80044,,0.71156,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Blastula,Embryo,Whole Organism,All anatomical structures 29725,SRR27485670,SRX23156879,SRS20107300,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,4 cell R2,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:1 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:2|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 1 hpf rep4,EV06003,EV06003,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06003.R1.fastq.gz,fastq,706095550.0,9366364.0,EV06003.R1.fastq.gz,0:75.39,A:204324355;C:140058731;G:159377323;T:202282197;N:52944,75,,,,204324355,140058731,159377323,202282197,52944,SRX23156879,SRS20107300,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.90788,,0.10297,,0.80168,,0.71073,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Cleavage,Embryo,Whole Organism,All anatomical structures 29726,SRR27485671,SRX23156878,SRS20107299,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,24h R3,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:24 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:3|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 24 hpf rep4,EV06014,EV06014,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06014.R1.fastq.gz,fastq,708984998.0,9425445.0,EV06014.R1.fastq.gz,0:75.22,A:219626080;C:141270902;G:161722995;T:186246245;N:118776,75,,,,219626080,141270902,161722995,186246245,118776,SRX23156878,SRS20107299,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.84881,,0.17975,,0.79693,,0.44149,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Pharyngula,Embryo,Whole Organism,All anatomical structures 29727,SRR27485672,SRX23156877,SRS20107298,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,Bud R3,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:10 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:3|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 10 hpf rep4,EV06013,EV06013,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06013.R1.fastq.gz,fastq,569494672.0,7557761.0,EV06013.R1.fastq.gz,0:75.35,A:170266388;C:110739260;G:124536859;T:163915551;N:36614,75,,,,170266388,110739260,124536859,163915551,36614,SRX23156877,SRS20107298,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.90037,,0.16195,,0.81308,,0.71641,,75,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Gastrula,Embryo,Whole Organism,All anatomical structures 29728,SRR27485673,SRX23156876,SRS20107297,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,Dome R3,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:5 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:3|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 5 hpf rep4,EV06012,EV06012,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06012.R1.fastq.gz,fastq,612322255.0,8128508.0,EV06012.R1.fastq.gz,0:75.33,A:190142665;C:119966127;G:131824584;T:170353082;N:35797,75,,,,190142665,119966127,131824584,170353082,35797,SRX23156876,SRS20107297,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.89638,,0.12215,,0.8196,,0.79176,,75,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Blastula,Embryo,Whole Organism,All anatomical structures 29729,SRR27485674,SRX23156875,SRS20107296,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,1K cell R3,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:3 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:3|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 3 hpf rep4,EV06011,EV06011,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV06011.R1.fastq.gz,fastq,516168257.0,6849932.0,EV06011.R1.fastq.gz,0:75.35,A:157131780;C:98595108;G:111327650;T:149089977;N:23742,75,,,,157131780,98595108,111327650,149089977,23742,SRX23156875,SRS20107296,SRA1783314,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.89456,,0.0693,,0.80306,,0.73611,,75,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-11,Blastula,Embryo,Whole Organism,All anatomical structures 29732,SRR27477292,SRX23148655,SRS20099371,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,24h R4,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:24 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:4|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 24 hpf rep4,EV09007,EV09007,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV09007.R1.fastq.gz,fastq,693872355.0,9217545.0,EV09007.R1.fastq.gz,0:75.28,A:207207066;C:136288214;G:150585299;T:199742228;N:49548,75,,,,207207066,136288214,150585299,199742228,49548,SRX23148655,SRS20099371,SRA1782413,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.89376,,0.11471,,0.79192,,0.60125,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-10,Pharyngula,Embryo,Whole Organism,All anatomical structures 29733,SRR27477293,SRX23148654,SRS20099366,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,Bud R4,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:10 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:4|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 10 hpf rep4,EV09006,EV09006,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV09006.R1.fastq.gz,fastq,476216388.0,6331468.0,EV09006.R1.fastq.gz,0:75.21,A:146002765;C:93329508;G:104039751;T:132799091;N:45273,75,,,,146002765,93329508,104039751,132799091,45273,SRX23148654,SRS20099366,SRA1782413,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.88768,,0.12305,,0.82696,,0.67338,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-10,Gastrula,Embryo,Whole Organism,All anatomical structures 29734,SRR27477294,SRX23148653,SRS20099369,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,Dome R4,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:5 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:4|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 5 hpf rep4,EV09005,EV09005,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV09005.R1.fastq.gz,fastq,1231107704.0,16463264.0,EV09005.R1.fastq.gz,0:74.78,A:408948044;C:228823967;G:256397453;T:336404532;N:533708,74,,,,408948044,228823967,256397453,336404532,533708,SRX23148653,SRS20099369,SRA1782413,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.84006,,0.08028,,0.80647,,0.73016,,73,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-10,Blastula,Embryo,Whole Organism,All anatomical structures 29735,SRR27477295,SRX23148652,SRS20099365,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,1K cell R4,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:3 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:4|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 3 hpf rep4,EV09004,EV09004,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV09004.R1.fastq.gz,fastq,471461315.0,6271281.0,EV09004.R1.fastq.gz,0:75.18,A:148103215;C:93173628;G:103496734;T:126647635;N:40103,75,,,,148103215,93173628,103496734,126647635,40103,SRX23148652,SRS20099365,SRA1782413,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.87715,,0.11105,,0.80606,,0.74204,,75,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-10,Blastula,Embryo,Whole Organism,All anatomical structures 29736,SRR27477296,SRX23148651,SRS20099370,SRP482074,PRJNA1061456,tRAM seq: tRNA abundance and modification analysis during zebrafish embryo development,PRJNA1061456,Other,,,,,,4 cell R4,,strain:TLAB fish|isolate:NA|breed:cross of zebrafish AB and the natural variant TL Tupfel Longfin|cultivar:NA|ecotype:NA|dev stage:1 hpf|collection date:2022|geo loc name:Austria|sex:mixed|tissue:whole embryo|replicate:4|BioSampleModel:Model organism or animal,,,,,,,,,mRNA seq of zebrafish: embryo 1 hpf rep4,EV09003,EV09003,RNA was extracted with Trizol and processed with QuantSeq three prime mRNA Seq Library Prep Kit FWD for Illumina Lexogen. 500 ng total RNA per sample. Single indexed QuantSeq libraries were QC checked on a Bioanalyzer 2100 Agilent using a High Sensitivity DNA Kit for correct insert size and quantified using Qubit dsDNA HS Assay Invitrogen. Pooled libraries were sequenced on a NextSeq500 instrument Illumina in 1x75bp single end sequencing mode,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,SINGLE,ILLUMINA,NextSeq 500,,SRP482074,,,EV09003.R1.fastq.gz,fastq,438955973.0,5837128.0,EV09003.R1.fastq.gz,0:75.20,A:134628611;C:87460856;G:98199538;T:118638244;N:28724,75,,,,134628611,87460856,98199538,118638244,28724,SRX23148651,SRS20099370,SRA1782413,Medical University of Vienna|Cell and Developmental Biology,Medical University of Vienna,1,0.89029,,0.11994,,0.80833,,0.72581,,76,,B,,usable mapping rate,illumina,nextseq,3prime,poly_a,lexogen,bulk,unknown,unknown,,Austria,2024-01-10,Cleavage,Embryo,Whole Organism,All anatomical structures 30671,SRR28178116,SRX23808192,SRS20631136,SRP492753,PRJNA1082072,Danio rerio Raw sequence reads,PRJNA1082072,Whole Genome Sequencing,RNA seq data of ace function in development,,,ace knock out,,Ace 5dpf,,strain:AB|breed:Artemia|age:5 dpf|collection date:2023 06 20|geo loc name:China|sex:pooled male and female|tissue:Whole embryo|birth date:2023 06 15|genotype:ace / |BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of Danio rerio,Ace5,Ace5,RNA seq of Danio rerio,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP492753,,,ace5dpf_1.fq.gz ace5dpf_2.fq.gz,fastq fastq,6270296100.0,20900987.0,ace5dpf 1.fq.gz,0:150 1:150,A:1724295687;C:1427908889;G:1421635888;T:1696367928;N:87708,150,150,,,1724295687,1427908889,1421635888,1696367928,87708,SRX23808192,SRS20631136,SRA1814700,ocean university of China|college of marine life sciences,ocean university of China,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2024-03-01,Larval,Larval,Whole Organism,All anatomical structures 30672,SRR28178117,SRX23808191,SRS20631133,SRP492753,PRJNA1082072,Danio rerio Raw sequence reads,PRJNA1082072,Whole Genome Sequencing,RNA seq data of ace function in development,,,wild type,,WT 5dpf,,strain:AB|breed:Artemia|age:5 dpf|collection date:2023 06 20|geo loc name:China|sex:pooled male and female|tissue:Whole embryo|birth date:2023 06 15|genotype:ace+/+|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of Danio rerio,WT5,WT5,RNA seq of Danio rerio,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP492753,,,WT5dpf_1.fq.gz WT5dpf_2.fq.gz,fastq fastq,6026322000.0,20087740.0,WT5dpf 1.fq.gz,0:150 1:150,A:1657462482;C:1372200290;G:1363936383;T:1632545363;N:177482,150,150,,,1657462482,1372200290,1363936383,1632545363,177482,SRX23808191,SRS20631133,SRA1814700,ocean university of China|college of marine life sciences,ocean university of China,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,China,2024-03-01,Larval,Larval,Whole Organism,All anatomical structures 31890,SRR28743285,SRX24309170,SRS21071681,SRP502786,PRJNA1102287,Zebrafish inppl1a stl445 mutant RNAseq,PRJNA1102287,Other,These are RNAseq data from pooled wild type and inppl1a stl445 Danio rerio mutant whole embryos at 3 dpf,,,inppl1a stl445 mutant sample C,,inppl1a stl445 mutant sample C,,strain:inppl1a mutant C|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:3 dpf|dev stage:3 dpf|collection date:not applicable|geo loc name:not applicable|sex:not applicable|tissue:whole embryo C|biomaterial provider:GRAY LAB|genotype:inppl1a mutant C|BioSampleModel:Model organism or animal,,,,,,,,,RNA Seq of inppl1a mutant C,stl445C,stl445C,Novagene,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP502786,,,stl445C_1.fq.gz stl445C_2.fq.gz,fastq fastq,9297920100.0,30993067.0,stl445C 1.fq.gz,0:150 1:150,A:2480150497;C:2183333189;G:2187548387;T:2446422923;N:465104,150,150,,,2480150497,2183333189,2187548387,2446422923,465104,SRX24309170,SRS21071681,SRA1848931,Univeristy of Texas - Dell Pediatrics Reseach Institute|Nutritional Sciences,Univeristy of Texas - Dell Pediatrics Reseach Institute,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-04-19,Larval,Larval,Whole Organism,All anatomical structures 31891,SRR28743286,SRX24309169,SRS21071679,SRP502786,PRJNA1102287,Zebrafish inppl1a stl445 mutant RNAseq,PRJNA1102287,Other,These are RNAseq data from pooled wild type and inppl1a stl445 Danio rerio mutant whole embryos at 3 dpf,,,inppl1a stl445 mutant sample B,,inppl1a stl445 mutant sample B,,strain:inppl1a mutant B|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:3 dpf|dev stage:3 dpf|collection date:not applicable|geo loc name:not applicable|sex:not applicable|tissue:whole embryo B|biomaterial provider:GRAY LAB|genotype:inppl1a mutant B|BioSampleModel:Model organism or animal,,,,,,,,,RNA Seq of inppl1a mutant B,stl445B,stl445B,Novagene,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP502786,,,stl445B_1.fq.gz stl445B_2.fq.gz,fastq fastq,7164288900.0,23880963.0,stl445B 1.fq.gz,0:150 1:150,A:1912903566;C:1681545796;G:1688486097;T:1881122778;N:230663,150,150,,,1912903566,1681545796,1688486097,1881122778,230663,SRX24309169,SRS21071679,SRA1848931,Univeristy of Texas - Dell Pediatrics Reseach Institute|Nutritional Sciences,Univeristy of Texas - Dell Pediatrics Reseach Institute,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-04-19,Larval,Larval,Whole Organism,All anatomical structures 31892,SRR28743287,SRX24309168,SRS21071678,SRP502786,PRJNA1102287,Zebrafish inppl1a stl445 mutant RNAseq,PRJNA1102287,Other,These are RNAseq data from pooled wild type and inppl1a stl445 Danio rerio mutant whole embryos at 3 dpf,,,inppl1a stl445 mutant sample A,,inppl1a stl445 mutant sample A,,strain:inppl1a mutant A|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:3 dpf|dev stage:3 dpf|collection date:not applicable|geo loc name:not applicable|sex:not applicable|tissue:whole embryo A|biomaterial provider:GRAY LAB|genotype:inppl1a mutant A|BioSampleModel:Model organism or animal,,,,,,,,,RNA Seq of inppl1a mutant A,stl445A,stl445A,Novagene,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP502786,,,stl445A_1.fq.gz stl445A_2.fq.gz,fastq fastq,6509496900.0,21698323.0,stl445A 1.fq.gz,0:150 1:150,A:1721159659;C:1544597555;G:1553920683;T:1689642737;N:176266,150,150,,,1721159659,1544597555,1553920683,1689642737,176266,SRX24309168,SRS21071678,SRA1848931,Univeristy of Texas - Dell Pediatrics Reseach Institute|Nutritional Sciences,Univeristy of Texas - Dell Pediatrics Reseach Institute,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-04-19,Larval,Larval,Whole Organism,All anatomical structures 31893,SRR28743288,SRX24309167,SRS21071677,SRP502786,PRJNA1102287,Zebrafish inppl1a stl445 mutant RNAseq,PRJNA1102287,Other,These are RNAseq data from pooled wild type and inppl1a stl445 Danio rerio mutant whole embryos at 3 dpf,,,AB d3 sample 3,,AB d3 sample 3,,strain:AB wild type 3|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:3 dpf|dev stage:3 dpf|collection date:not applicable|geo loc name:not applicable|sex:not applicable|tissue:whole embryo 3|biomaterial provider:GRAY LAB|genotype:AB wild type 3|BioSampleModel:Model organism or animal,,,,,,,,,RNA Seq of AB wild type 3,AB3,AB3,Novagene,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP502786,,,AB3_1.fq.gz AB3_2.fq.gz,fastq fastq,6003236700.0,20010789.0,AB3 1.fq.gz,0:150 1:150,A:1587549671;C:1423913333;G:1427635736;T:1563843191;N:294769,150,150,,,1587549671,1423913333,1427635736,1563843191,294769,SRX24309167,SRS21071677,SRA1848931,Univeristy of Texas - Dell Pediatrics Reseach Institute|Nutritional Sciences,Univeristy of Texas - Dell Pediatrics Reseach Institute,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-04-19,Larval,Larval,Whole Organism,All anatomical structures 31894,SRR28743289,SRX24309166,SRS21071675,SRP502786,PRJNA1102287,Zebrafish inppl1a stl445 mutant RNAseq,PRJNA1102287,Other,These are RNAseq data from pooled wild type and inppl1a stl445 Danio rerio mutant whole embryos at 3 dpf,,,AB d3 sample 2,,AB d3 sample 2,,strain:AB wild type 2|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:3 dpf|dev stage:3 dpf|collection date:not applicable|geo loc name:not applicable|sex:not applicable|tissue:whole embryo 2|biomaterial provider:GRAY LAB|genotype:AB wild type 2|BioSampleModel:Model organism or animal,,,,,,,,,RNA Seq of AB wild type 2,AB2,AB2,Novagene,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP502786,,,AB2_1.fq.gz AB2_2.fq.gz,fastq fastq,6725792700.0,22419309.0,AB2 1.fq.gz,0:150 1:150,A:1783642195;C:1591564351;G:1592249093;T:1758002304;N:334757,150,150,,,1783642195,1591564351,1592249093,1758002304,334757,SRX24309166,SRS21071675,SRA1848931,Univeristy of Texas - Dell Pediatrics Reseach Institute|Nutritional Sciences,Univeristy of Texas - Dell Pediatrics Reseach Institute,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-04-19,Larval,Larval,Whole Organism,All anatomical structures 31895,SRR28743290,SRX24309165,SRS21071676,SRP502786,PRJNA1102287,Zebrafish inppl1a stl445 mutant RNAseq,PRJNA1102287,Other,These are RNAseq data from pooled wild type and inppl1a stl445 Danio rerio mutant whole embryos at 3 dpf,,,AB d3 sample 1,,AB d3 sample 1,,strain:AB wild type 1|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:3 dpf|dev stage:3 dpf|collection date:not applicable|geo loc name:not applicable|sex:not applicable|tissue:whole embryo 1|biomaterial provider:GRAY LAB|genotype:AB wild type 1|BioSampleModel:Model organism or animal,,,,,,,,,RNA Seq of AB wild type 1,AB1,AB1,Novagene,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq 6000,,SRP502786,,,AB1_1.fq.gz AB1_2.fq.gz,fastq fastq,7650139500.0,25500465.0,AB1 1.fq.gz,0:150 1:150,A:2028571272;C:1810040115;G:1813654945;T:1997492787;N:380381,150,150,,,2028571272,1810040115,1813654945,1997492787,380381,SRX24309165,SRS21071676,SRA1848931,Univeristy of Texas - Dell Pediatrics Reseach Institute|Nutritional Sciences,Univeristy of Texas - Dell Pediatrics Reseach Institute,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-04-19,Larval,Larval,Whole Organism,All anatomical structures 32437,SRR29249474,SRX24767688,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1 only for fig4 and figsupp10,weiq10,weiq10,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-only-rep1_R1.fq.gz ABEUmax-ex1-only-rep1_R2.fq.gz,fastq fastq,6282249300.0,20940831.0,ABEUmax ex1 only rep1 R1.fq.gz,0:150 1:150,A:1756899532;C:1390175279;G:1406729636;T:1728418442;N:26411,150,150,,,1756899532,1390175279,1406729636,1728418442,26411,SRX24767688,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32438,SRR29249475,SRX24767687,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax only for fig4 and figsupp10,weiq9,weiq9,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-only-rep3_R1.fq.gz ABEUmax-only-rep3_R2.fq.gz,fastq fastq,6410258400.0,21367528.0,ABEUmax only rep3 R1.fq.gz,0:150 1:150,A:1796941092;C:1415805398;G:1424825270;T:1772660117;N:26523,150,150,,,1796941092,1415805398,1424825270,1772660117,26523,SRX24767687,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32439,SRR29249476,SRX24767686,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax only for fig4 and figsupp10,weiq8,weiq8,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-only-rep2_R1.fq.gz ABEUmax-only-rep2_R2.fq.gz,fastq fastq,7389619200.0,24632064.0,ABEUmax only rep2 R1.fq.gz,0:150 1:150,A:2026204447;C:1667867375;G:1691882291;T:2003584205;N:80882,150,150,,,2026204447,1667867375,1691882291,2003584205,80882,SRX24767686,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32440,SRR29249477,SRX24767685,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax only for fig4 and figsupp10,weiq7,weiq7,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-only-rep1_R1.fq.gz ABEUmax-only-rep1_R2.fq.gz,fastq fastq,11336033400.0,37786778.0,ABEUmax only rep1 R1.fq.gz,0:150 1:150,A:3135246137;C:2536541212;G:2564827351;T:3099296340;N:122360,150,150,,,3135246137,2536541212,2564827351,3099296340,122360,SRX24767685,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32441,SRR29249478,SRX24767684,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e only for fig4 and figsupp10,weiq6,weiq6,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-only-rep3_R1.fq.gz ABE8e-only-rep3_R2.fq.gz,fastq fastq,5719869600.0,19066232.0,ABE8e only rep3 R1.fq.gz,0:150 1:150,A:1608480551;C:1257475652;G:1266100141;T:1587789911;N:23345,150,150,,,1608480551,1257475652,1266100141,1587789911,23345,SRX24767684,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32442,SRR29249479,SRX24767683,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e only for fig4 and figsupp10,weiq5,weiq5,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-only-rep2_R1.fq.gz ABE8e-only-rep2_R2.fq.gz,fastq fastq,7391481300.0,24638271.0,ABE8e only rep2 R1.fq.gz,0:150 1:150,A:2037764745;C:1665759801;G:1685514060;T:2002411849;N:30845,150,150,,,2037764745,1665759801,1685514060,2002411849,30845,SRX24767683,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32443,SRR29249480,SRX24767682,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tp53 gRNA for figsupp10,weiq39,weiq39,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tp53-rep3_R1.fq.gz ABEUmax-ex2-tp53-rep3_R2.fq.gz,fastq fastq,5803077300.0,19343591.0,ABEUmax ex2 tp53 rep3 R1.fq.gz,0:150 1:150,A:1617761226;C:1287691319;G:1296461744;T:1601139422;N:23589,150,150,,,1617761226,1287691319,1296461744,1601139422,23589,SRX24767682,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32444,SRR29249481,SRX24767681,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tp53 gRNA for figsupp10,weiq38,weiq38,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tp53-rep2_R1.fq.gz ABEUmax-ex2-tp53-rep2_R2.fq.gz,fastq fastq,6553627800.0,21845426.0,ABEUmax ex2 tp53 rep2 R1.fq.gz,0:150 1:150,A:1823059776;C:1459120344;G:1471795924;T:1799625591;N:26165,150,150,,,1823059776,1459120344,1471795924,1799625591,26165,SRX24767681,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32445,SRR29249482,SRX24767680,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tp53 gRNA for figsupp10,weiq37,weiq37,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tp53-rep1_R1.fq.gz ABEUmax-ex2-tp53-rep1_R2.fq.gz,fastq fastq,5478292800.0,18260976.0,ABEUmax ex2 tp53 rep1 R1.fq.gz,0:150 1:150,A:1532855737;C:1211392548;G:1218403742;T:1515617884;N:22889,150,150,,,1532855737,1211392548,1218403742,1515617884,22889,SRX24767680,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32446,SRR29249483,SRX24767679,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tp53 gRNA for figsupp10,weiq36,weiq36,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tp53-rep3_R1.fq.gz ABEUmax-ex1-tp53-rep3_R2.fq.gz,fastq fastq,5702600100.0,19008667.0,ABEUmax ex1 tp53 rep3 R1.fq.gz,0:150 1:150,A:1592234548;C:1265657347;G:1274347831;T:1570335937;N:24437,150,150,,,1592234548,1265657347,1274347831,1570335937,24437,SRX24767679,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32447,SRR29249484,SRX24767678,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tp53 gRNA for figsupp10,weiq35,weiq35,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tp53-rep2_R1.fq.gz ABEUmax-ex1-tp53-rep2_R2.fq.gz,fastq fastq,5673681300.0,18912271.0,ABEUmax ex1 tp53 rep2 R1.fq.gz,0:150 1:150,A:1584159831;C:1258740162;G:1265184204;T:1565573424;N:23679,150,150,,,1584159831,1258740162,1265184204,1565573424,23679,SRX24767678,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32448,SRR29249485,SRX24767677,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tp53 gRNA for figsupp10,weiq34,weiq34,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tp53-rep1_R1.fq.gz ABEUmax-ex1-tp53-rep1_R2.fq.gz,fastq fastq,5850351900.0,19501173.0,ABEUmax ex1 tp53 rep1 R1.fq.gz,0:150 1:150,A:1637621159;C:1292895963;G:1300389598;T:1619408204;N:36976,150,150,,,1637621159,1292895963,1300389598,1619408204,36976,SRX24767677,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32449,SRR29249486,SRX24767676,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tp53 gRNA for figsupp10,weiq33,weiq33,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tp53-rep3_R1.fq.gz ABEUmax-tp53-rep3_R2.fq.gz,fastq fastq,5560424400.0,18534748.0,ABEUmax tp53 rep3 R1.fq.gz,0:150 1:150,A:1573488930;C:1210871236;G:1216440896;T:1559594579;N:28759,150,150,,,1573488930,1210871236,1216440896,1559594579,28759,SRX24767676,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32450,SRR29249487,SRX24767675,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tp53 gRNA for figsupp10,weiq32,weiq32,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tp53-rep2_R1.fq.gz ABEUmax-tp53-rep2_R2.fq.gz,fastq fastq,7064616300.0,23548721.0,ABEUmax tp53 rep2 R1.fq.gz,0:150 1:150,A:1963220033;C:1575155090;G:1588646272;T:1937565246;N:29659,150,150,,,1963220033,1575155090,1588646272,1937565246,29659,SRX24767675,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32451,SRR29249488,SRX24767674,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tp53 gRNA for figsupp10,weiq31,weiq31,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tp53-rep1_R1.fq.gz ABEUmax-tp53-rep1_R2.fq.gz,fastq fastq,5574916500.0,18583055.0,ABEUmax tp53 rep1 R1.fq.gz,0:150 1:150,A:1560082887;C:1233222110;G:1242344240;T:1539244662;N:22601,150,150,,,1560082887,1233222110,1242344240,1539244662,22601,SRX24767674,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32452,SRR29249489,SRX24767673,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e only for fig4 and figsupp10,weiq4,weiq4,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-only-rep1_R1.fq.gz ABE8e-only-rep1_R2.fq.gz,fastq fastq,6671069700.0,22236899.0,ABE8e only rep1 R1.fq.gz,0:150 1:150,A:1864009996;C:1478815930;G:1487036206;T:1841181233;N:26335,150,150,,,1864009996,1478815930,1487036206,1841181233,26335,SRX24767673,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32453,SRR29249490,SRX24767672,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tp53 gRNA for figsupp10,weiq30,weiq30,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tp53-rep3_R1.fq.gz ABE8e-tp53-rep3_R2.fq.gz,fastq fastq,5472580200.0,18241934.0,ABE8e tp53 rep3 R1.fq.gz,0:150 1:150,A:1529609161;C:1210720423;G:1218497152;T:1513730632;N:22832,150,150,,,1529609161,1210720423,1218497152,1513730632,22832,SRX24767672,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32454,SRR29249491,SRX24767671,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tp53 gRNA for figsupp10,weiq29,weiq29,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tp53-rep2_R1.fq.gz ABE8e-tp53-rep2_R2.fq.gz,fastq fastq,5775198300.0,19250661.0,ABE8e tp53 rep2 R1.fq.gz,0:150 1:150,A:1615797642;C:1277695015;G:1286105005;T:1595565162;N:35476,150,150,,,1615797642,1277695015,1286105005,1595565162,35476,SRX24767671,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32455,SRR29249492,SRX24767670,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tp53 gRNA for figsupp10,weiq28,weiq28,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tp53-rep1_R1.fq.gz ABE8e-tp53-rep1_R2.fq.gz,fastq fastq,5982304200.0,19941014.0,ABE8e tp53 rep1 R1.fq.gz,0:150 1:150,A:1664274171;C:1331728039;G:1341859951;T:1644417739;N:24300,150,150,,,1664274171,1331728039,1341859951,1644417739,24300,SRX24767670,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32456,SRR29249493,SRX24767669,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tyr g4 gRNA for fig4,weiq27,weiq27,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tyr-g4-rep3_R1.fq.gz ABEUmax-ex2-tyr-g4-rep3_R2.fq.gz,fastq fastq,6163283400.0,20544278.0,ABEUmax ex2 tyr g4 rep3 R1.fq.gz,0:150 1:150,A:1719817416;C:1368111115;G:1378451421;T:1696857842;N:45606,150,150,,,1719817416,1368111115,1378451421,1696857842,45606,SRX24767669,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32457,SRR29249494,SRX24767668,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tyr g4 gRNA for fig4,weiq26,weiq26,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tyr-g4-rep2_R1.fq.gz ABEUmax-ex2-tyr-g4-rep2_R2.fq.gz,fastq fastq,6053987100.0,20179957.0,ABEUmax ex2 tyr g4 rep2 R1.fq.gz,0:150 1:150,A:1690768868;C:1342177860;G:1354472933;T:1666542324;N:25115,150,150,,,1690768868,1342177860,1354472933,1666542324,25115,SRX24767668,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32458,SRR29249495,SRX24767667,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2+tyr g4 gRNA for fig4,weiq25,weiq25,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-tyr-g4-rep1_R1.fq.gz ABEUmax-ex2-tyr-g4-rep1_R2.fq.gz,fastq fastq,5899971000.0,19666570.0,ABEUmax ex2 tyr g4 rep1 R1.fq.gz,0:150 1:150,A:1647942416;C:1309207091;G:1318063577;T:1624735976;N:21940,150,150,,,1647942416,1309207091,1318063577,1624735976,21940,SRX24767667,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32459,SRR29249496,SRX24767666,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tyr g4 gRNA for fig4,weiq24,weiq24,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tyr-g4-rep3_R1.fq.gz ABEUmax-ex1-tyr-g4-rep3_R2.fq.gz,fastq fastq,7437809400.0,24792698.0,ABEUmax ex1 tyr g4 rep3 R1.fq.gz,0:150 1:150,A:2076956731;C:1650332418;G:1666043372;T:2044446120;N:30759,150,150,,,2076956731,1650332418,1666043372,2044446120,30759,SRX24767666,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32460,SRR29249497,SRX24767665,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tyr g4 gRNA for fig4,weiq23,weiq23,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tyr-g4-rep2_R1.fq.gz ABEUmax-ex1-tyr-g4-rep2_R2.fq.gz,fastq fastq,9322655400.0,31075518.0,ABEUmax ex1 tyr g4 rep2 R1.fq.gz,0:150 1:150,A:2594468604;C:2077629273;G:2094178897;T:2556340809;N:37817,150,150,,,2594468604,2077629273,2094178897,2556340809,37817,SRX24767665,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32461,SRR29249498,SRX24767664,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1+tyr g4 gRNA for fig4,weiq22,weiq22,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-tyr-g4-rep1_R1.fq.gz ABEUmax-ex1-tyr-g4-rep1_R2.fq.gz,fastq fastq,8997229800.0,29990766.0,ABEUmax ex1 tyr g4 rep1 R1.fq.gz,0:150 1:150,A:2496600223;C:2012455168;G:2029289770;T:2458847443;N:37196,150,150,,,2496600223,2012455168,2029289770,2458847443,37196,SRX24767664,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32462,SRR29249499,SRX24767663,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tyr g4 gRNA for fig4,weiq21,weiq21,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tyr-g4-rep3_R1.fq.gz ABEUmax-tyr-g4-rep3_R2.fq.gz,fastq fastq,6046479300.0,20154931.0,ABEUmax tyr g4 rep3 R1.fq.gz,0:150 1:150,A:1690489526;C:1340484296;G:1343425025;T:1672042239;N:38214,150,150,,,1690489526,1340484296,1343425025,1672042239,38214,SRX24767663,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32463,SRR29249500,SRX24767662,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control for fig4 and figsupp10,weiq3,weiq3,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,blank-rep3_R1.fq.gz blank-rep3_R2.fq.gz,fastq fastq,5916067800.0,19720226.0,blank rep3 R1.fq.gz,0:150 1:150,A:1654283259;C:1308680421;G:1317350949;T:1635716655;N:36516,150,150,,,1654283259,1308680421,1317350949,1635716655,36516,SRX24767662,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32464,SRR29249501,SRX24767661,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tyr g4 gRNA for fig4,weiq20,weiq20,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tyr-g4-rep2_R1.fq.gz ABEUmax-tyr-g4-rep2_R2.fq.gz,fastq fastq,9783360000.0,32611200.0,ABEUmax tyr g4 rep2 R1.fq.gz,0:150 1:150,A:2719027222;C:2183139548;G:2202789910;T:2678363595;N:39725,150,150,,,2719027222,2183139548,2202789910,2678363595,39725,SRX24767661,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32465,SRR29249502,SRX24767660,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax+tyr g4 gRNA for fig4,weiq19,weiq19,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-tyr-g4-rep1_R1.fq.gz ABEUmax-tyr-g4-rep1_R2.fq.gz,fastq fastq,6132960900.0,20443203.0,ABEUmax tyr g4 rep1 R1.fq.gz,0:150 1:150,A:1713443234;C:1359953330;G:1369858637;T:1689667341;N:38358,150,150,,,1713443234,1359953330,1369858637,1689667341,38358,SRX24767660,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32466,SRR29249503,SRX24767659,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tyr g4 gRNA for fig4,weiq18,weiq18,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tyr-g4-rep3_R1.fq.gz ABE8e-tyr-g4-rep3_R2.fq.gz,fastq fastq,10563257400.0,35210858.0,ABE8e tyr g4 rep3 R1.fq.gz,0:150 1:150,A:2936805440;C:2355014311;G:2373187903;T:2898205803;N:43943,150,150,,,2936805440,2355014311,2373187903,2898205803,43943,SRX24767659,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32467,SRR29249504,SRX24767658,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tyr g4 gRNA for fig4,weiq17,weiq17,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tyr-g4-rep2_R1.fq.gz ABE8e-tyr-g4-rep2_R2.fq.gz,fastq fastq,6284594400.0,20948648.0,ABE8e tyr g4 rep2 R1.fq.gz,0:150 1:150,A:1749704654;C:1397878340;G:1413270817;T:1723715159;N:25430,150,150,,,1749704654,1397878340,1413270817,1723715159,25430,SRX24767658,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32468,SRR29249505,SRX24767657,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABE8e+tyr g4 gRNA for fig4,weiq16,weiq16,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABE8e-tyr-g4-rep1_R1.fq.gz ABE8e-tyr-g4-rep1_R2.fq.gz,fastq fastq,6074610900.0,20248703.0,ABE8e tyr g4 rep1 R1.fq.gz,0:150 1:150,A:1685268364;C:1357083683;G:1371702610;T:1660530508;N:25735,150,150,,,1685268364,1357083683,1371702610,1660530508,25735,SRX24767657,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32469,SRR29249506,SRX24767656,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2 only for fig4 and figsupp10,weiq15,weiq15,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-only-rep3_R1.fq.gz ABEUmax-ex2-only-rep3_R2.fq.gz,fastq fastq,8344627500.0,27815425.0,ABEUmax ex2 only rep3 R1.fq.gz,0:150 1:150,A:2329541832;C:1850818895;G:1863621349;T:2300610494;N:34930,150,150,,,2329541832,1850818895,1863621349,2300610494,34930,SRX24767656,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32470,SRR29249507,SRX24767655,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2 only for fig4 and figsupp10,weiq14,weiq14,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-only-rep2_R1.fq.gz ABEUmax-ex2-only-rep2_R2.fq.gz,fastq fastq,5572436400.0,18574788.0,ABEUmax ex2 only rep2 R1.fq.gz,0:150 1:150,A:1553125380;C:1238548658;G:1250549536;T:1530189551;N:23275,150,150,,,1553125380,1238548658,1250549536,1530189551,23275,SRX24767655,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32471,SRR29249508,SRX24767654,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex2 only for fig4 and figsupp10,weiq13,weiq13,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex2-only-rep1_R1.fq.gz ABEUmax-ex2-only-rep1_R2.fq.gz,fastq fastq,5559912900.0,18533043.0,ABEUmax ex2 only rep1 R1.fq.gz,0:150 1:150,A:1557612759;C:1229187540;G:1236208646;T:1536881156;N:22799,150,150,,,1557612759,1229187540,1236208646,1536881156,22799,SRX24767654,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32472,SRR29249509,SRX24767653,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1 only for fig4 and figsupp10,weiq12,weiq12,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-only-rep3_R1.fq.gz ABEUmax-ex1-only-rep3_R2.fq.gz,fastq fastq,8929598100.0,29765327.0,ABEUmax ex1 only rep3 R1.fq.gz,0:150 1:150,A:2488796078;C:1985527444;G:2002596512;T:2452641331;N:36735,150,150,,,2488796078,1985527444,2002596512,2452641331,36735,SRX24767653,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32473,SRR29249510,SRX24767652,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of injected ABEUmax ex1 only for fig4 and figsupp10,weiq11,weiq11,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,ABEUmax-ex1-only-rep2_R1.fq.gz ABEUmax-ex1-only-rep2_R2.fq.gz,fastq fastq,5984311200.0,19947704.0,ABEUmax ex1 only rep2 R1.fq.gz,0:150 1:150,A:1677434145;C:1320957982;G:1334799050;T:1651095011;N:25012,150,150,,,1677434145,1320957982,1334799050,1651095011,25012,SRX24767652,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32474,SRR29249511,SRX24767651,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control for fig4 and figsupp10,weiq2,weiq2,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,blank-rep2_R1.fq.gz blank-rep2_R2.fq.gz,fastq fastq,5470137600.0,18233792.0,blank rep2 R1.fq.gz,0:150 1:150,A:1521716947;C:1217660080;G:1226314116;T:1504423565;N:22892,150,150,,,1521716947,1217660080,1226314116,1504423565,22892,SRX24767651,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32475,SRR29249512,SRX24767650,SRS21486855,SRP511062,PRJNA1118794,ABE Ultramax for high efficiency biallelic adenine base editing,PRJNA1118794,Other,RNA off target evaluation,,,,,ABE Umax project RNA off target NGS data,,strain:AB|isolate:not applicable|breed:not applicable|cultivar:not applicable|ecotype:not applicable|age:not applicable|dev stage:2dpf|collection date:2024 01 13|geo loc name:China|sex:pooled male and female|tissue:whole embryos|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control for fig4 and figsupp10,weiq1,weiq1,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,HiSeq X Ten,,SRP511062,,,blank-rep1_R1.fq.gz blank-rep1_R2.fq.gz,fastq fastq,5844893700.0,19482979.0,blank rep1 R1.fq.gz,0:150 1:150,A:1627504221;C:1298537202;G:1308079845;T:1610735356;N:37076,150,150,,,1627504221,1298537202,1308079845,1610735356,37076,SRX24767650,SRS21486855,SRA1884869,OMRF|Gene and human disease,OMRF,,,,,,,,,,,,B,B,biological fallback assumption,illumina,hiseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-05-31,Hatching,Embryo,Whole Organism,All anatomical structures 32638,SRR31861959,SRX27221939,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,med11 F0 + human MED11,G10,G10,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G10_1.fq.gz G10_2.fq.gz,fastq fastq,7852079700.0,26173599.0,G10 1.fq.gz,0:150 1:150,A:2108896154;C:1835554515;G:1826135414;T:2081472870;N:20747,150,150,,,2108896154,1835554515,1826135414,2081472870,20747,SRX27221939,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32639,SRR31861960,SRX27221938,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,med11 F0,G9,G9,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G9_1.fq.gz G9_2.fq.gz,fastq fastq,6222103500.0,20740345.0,G9 1.fq.gz,0:150 1:150,A:1681574896;C:1443002759;G:1436171011;T:1661295855;N:58979,150,150,,,1681574896,1443002759,1436171011,1661295855,58979,SRX27221938,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32640,SRR31861961,SRX27221937,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,med11 F0,G8,G8,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G8_1.fq.gz G8_2.fq.gz,fastq fastq,7546694100.0,25155647.0,G8 1.fq.gz,0:150 1:150,A:2046668747;C:1744610714;G:1733980515;T:2021414389;N:19735,150,150,,,2046668747,1744610714,1733980515,2021414389,19735,SRX27221937,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32641,SRR31861962,SRX27221936,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,med11 F0,G7,G7,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G7_1.fq.gz G7_2.fq.gz,fastq fastq,8581690200.0,28605634.0,G7 1.fq.gz,0:150 1:150,A:2329907623;C:1980616318;G:1971860661;T:2299282869;N:22729,150,150,,,2329907623,1980616318,1971860661,2299282869,22729,SRX27221936,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32642,SRR31861963,SRX27221935,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,Cas9 injected,G6,G6,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G6_1.fq.gz G6_2.fq.gz,fastq fastq,7171681200.0,23905604.0,G6 1.fq.gz,0:150 1:150,A:1944384033;C:1657711698;G:1652038487;T:1917518927;N:28055,150,150,,,1944384033,1657711698,1652038487,1917518927,28055,SRX27221935,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32643,SRR31861964,SRX27221934,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,Cas9 injected,G5,G5,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G5_1.fq.gz G5_2.fq.gz,fastq fastq,5868646800.0,19562156.0,G5 1.fq.gz,0:150 1:150,A:1588507186;C:1360652261;G:1351680636;T:1567791336;N:15381,150,150,,,1588507186,1360652261,1351680636,1567791336,15381,SRX27221934,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32644,SRR31861965,SRX27221933,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,Cas9 injected,G4,G4,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G4_1.fq.gz G4_2.fq.gz,fastq fastq,8529724500.0,28432415.0,G4 1.fq.gz,0:150 1:150,A:2315348695;C:1970687014;G:1959370540;T:2284295801;N:22450,150,150,,,2315348695,1970687014,1959370540,2284295801,22450,SRX27221933,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32645,SRR31861966,SRX27221932,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,uninjected,G3,G3,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G3_1.fq.gz G3_2.fq.gz,fastq fastq,5872618500.0,19575395.0,G3 1.fq.gz,0:150 1:150,A:1593395135;C:1357046637;G:1349138867;T:1573022101;N:15760,150,150,,,1593395135,1357046637,1349138867,1573022101,15760,SRX27221932,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32646,SRR31861967,SRX27221931,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,wars1 F0 + human WARS1,G18,G18,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G18_1.fq.gz G18_2.fq.gz,fastq fastq,7211940900.0,24039803.0,G18 1.fq.gz,0:150 1:150,A:1950979145;C:1669606218;G:1666840192;T:1924463650;N:51695,150,150,,,1950979145,1669606218,1666840192,1924463650,51695,SRX27221931,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32647,SRR31861968,SRX27221930,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,wars1 F0 + human WARS1,G17,G17,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G17_1.fq.gz G17_2.fq.gz,fastq fastq,6793816500.0,22646055.0,G17 1.fq.gz,0:150 1:150,A:1841310854;C:1571063574;G:1568303946;T:1813094152;N:43974,150,150,,,1841310854,1571063574,1568303946,1813094152,43974,SRX27221930,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32648,SRR31861969,SRX27221929,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,wars1 F0 + human WARS1,G16,G16,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G16_1.fq.gz G16_2.fq.gz,fastq fastq,8484884100.0,28282947.0,G16 1.fq.gz,0:150 1:150,A:2286113460;C:1973925387;G:1968769805;T:2256052958;N:22490,150,150,,,2286113460,1973925387,1968769805,2256052958,22490,SRX27221929,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32649,SRR31861970,SRX27221928,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,wars1 F0,G15,G15,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G15_1.fq.gz G15_2.fq.gz,fastq fastq,7420511100.0,24735037.0,G15 1.fq.gz,0:150 1:150,A:1994378769;C:1730931741;G:1728048848;T:1967131928;N:19814,150,150,,,1994378769,1730931741,1728048848,1967131928,19814,SRX27221928,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32650,SRR31861971,SRX27221927,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,wars1 F0,G14,G14,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G14_1.fq.gz G14_2.fq.gz,fastq fastq,6127647000.0,20425490.0,G14 1.fq.gz,0:150 1:150,A:1649295191;C:1426223381;G:1425169683;T:1626937613;N:21132,150,150,,,1649295191,1426223381,1425169683,1626937613,21132,SRX27221927,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32651,SRR31861972,SRX27221926,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,wars1 F0,G13,G13,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G13_1.fq.gz G13_2.fq.gz,fastq fastq,7137649800.0,23792166.0,G13 1.fq.gz,0:150 1:150,A:1913297804;C:1669344625;G:1666478136;T:1888510414;N:18821,150,150,,,1913297804,1669344625,1666478136,1888510414,18821,SRX27221926,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32652,SRR31861973,SRX27221925,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,med11 F0 + human MED11,G12,G12,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G12_1.fq.gz G12_2.fq.gz,fastq fastq,5899210800.0,19664036.0,G12 1.fq.gz,0:150 1:150,A:1606864731;C:1358086900;G:1348623939;T:1585619394;N:15836,150,150,,,1606864731,1358086900,1348623939,1585619394,15836,SRX27221925,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32653,SRR31861974,SRX27221924,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,med11 F0 + human MED11,G11,G11,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G11_1.fq.gz G11_2.fq.gz,fastq fastq,8103856200.0,27012854.0,G11 1.fq.gz,0:150 1:150,A:2196012200;C:1876726376;G:1864679253;T:2166417500;N:20871,150,150,,,2196012200,1876726376,1864679253,2166417500,20871,SRX27221924,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32654,SRR31861975,SRX27221923,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,uninjected,G2,G2,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G2_1.fq.gz G2_2.fq.gz,fastq fastq,6744476700.0,22481589.0,G2 1.fq.gz,0:150 1:150,A:1825621916;C:1561506257;G:1555775898;T:1801554799;N:17830,150,150,,,1825621916,1561506257,1555775898,1801554799,17830,SRX27221923,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32655,SRR31861976,SRX27221922,SRS23670726,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,wars1 med11 F0 RNA seq,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2024 07 02|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,uninjected,G1,G1,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,G1_1.fq.gz G1_2.fq.gz,fastq fastq,6833669400.0,22778898.0,G1 1.fq.gz,0:150 1:150,A:1866895960;C:1568378121;G:1559312160;T:1839065716;N:17443,150,150,,,1866895960,1568378121,1559312160,1839065716,17443,SRX27221922,SRS23670726,SRA2043117,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32656,SRR31861706,SRX27221705,SRS23670514,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,Cas9,,strain:TAB 5|isolate:Cas9|age:3 dpf|collection date:2024 07 01|geo loc name:USA: Oklahoma City|sex:unknown|tissue:whole fish|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of Cas9,B6,B6,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,B6_R1_001.fastq.gz B6_R2_001.fastq.gz,fastq fastq,13501557488.0,44707144.0,B6 R1 001.fastq.gz,0:151 1:151,A:3661843346;C:2993198296;G:3270220608;T:3576215389;N:79849,151,151,,,3661843346,2993198296,3270220608,3576215389,79849,SRX27221705,SRS23670514,SRA2043079,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32657,SRR31861707,SRX27221704,SRS23670514,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,Cas9,,strain:TAB 5|isolate:Cas9|age:3 dpf|collection date:2024 07 01|geo loc name:USA: Oklahoma City|sex:unknown|tissue:whole fish|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of Cas9,B5,B5,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,B5_R1_001.fastq.gz B5_R2_001.fastq.gz,fastq fastq,12448713914.0,41220907.0,B5 R1 001.fastq.gz,0:151 1:151,A:3372468413;C:2748420869;G:3030254166;T:3297495700;N:74766,151,151,,,3372468413,2748420869,3030254166,3297495700,74766,SRX27221704,SRS23670514,SRA2043079,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32658,SRR31861708,SRX27221703,SRS23670514,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,Cas9,,strain:TAB 5|isolate:Cas9|age:3 dpf|collection date:2024 07 01|geo loc name:USA: Oklahoma City|sex:unknown|tissue:whole fish|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of Cas9,B4,B4,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,B4_R1_001.fastq.gz B4_R2_001.fastq.gz,fastq fastq,20239141852.0,67017026.0,B4 R1 001.fastq.gz,0:151 1:151,A:5457329110;C:4495644991;G:4971524893;T:5314522652;N:120206,151,151,,,5457329110,4495644991,4971524893,5314522652,120206,SRX27221703,SRS23670514,SRA2043079,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32659,SRR31861709,SRX27221702,SRS23670513,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,uninjected,,strain:TAB 5|isolate:uninjected|age:3 dpf|collection date:2024 07 01|geo loc name:USA: Oklahoma City|sex:unknown|tissue:whole fish|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control,B3,B3,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,B3_R1_001.fastq.gz B3_R2_001.fastq.gz,fastq fastq,14521776606.0,48085353.0,B3 R1 001.fastq.gz,0:151 1:151,A:3925750703;C:3223849989;G:3538964801;T:3833125506;N:85607,151,151,,,3925750703,3223849989,3538964801,3833125506,85607,SRX27221702,SRS23670513,SRA2043079,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32660,SRR31861710,SRX27221701,SRS23670513,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,uninjected,,strain:TAB 5|isolate:uninjected|age:3 dpf|collection date:2024 07 01|geo loc name:USA: Oklahoma City|sex:unknown|tissue:whole fish|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control,B2,B2,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,B2_R1_001.fastq.gz B2_R2_001.fastq.gz,fastq fastq,14630598078.0,48445689.0,B2 R1 001.fastq.gz,0:151 1:151,A:3965482285;C:3239118437;G:3551363729;T:3874546636;N:86991,151,151,,,3965482285,3239118437,3551363729,3874546636,86991,SRX27221701,SRS23670513,SRA2043079,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32661,SRR31861711,SRX27221700,SRS23670513,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,uninjected,,strain:TAB 5|isolate:uninjected|age:3 dpf|collection date:2024 07 01|geo loc name:USA: Oklahoma City|sex:unknown|tissue:whole fish|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq of un injected control,B1,B1,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,B1_R1_001.fastq.gz B1_R2_001.fastq.gz,fastq fastq,15399860330.0,50992915.0,B1 R1 001.fastq.gz,0:151 1:151,A:4180325657;C:3419342534;G:3714765068;T:4085336432;N:90639,151,151,,,4180325657,3419342534,3714765068,4085336432,90639,SRX27221700,SRS23670513,SRA2043079,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-31,Larval,Larval,Whole Organism,All anatomical structures 32662,SRR31857863,SRX27217641,SRS23666642,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,hars F0,,strain:TAB 5|isolate:F0|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,hars crispant 3dpf,H10,H10,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H10_S12_R1_001.fastq.gz H10_S12_R2_001.fastq.gz,fastq fastq,15474357086.0,51239593.0,H10 S12 R1 001.fastq.gz,0:151 1:151,A:4153925954;C:3479597658;G:3742917138;T:4097799869;N:116467,151,151,,,4153925954,3479597658,3742917138,4097799869,116467,SRX27217641,SRS23666642,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32663,SRR31857864,SRX27217640,SRS23666642,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,hars F0,,strain:TAB 5|isolate:F0|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,hars crispant 3dpf,H9,H9,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H9_S11_R1_001.fastq.gz H9_S11_R2_001.fastq.gz,fastq fastq,11454742522.0,37929611.0,H9 S11 R1 001.fastq.gz,0:151 1:151,A:3010869380;C:2521267781;G:2960545122;T:2961976047;N:84192,151,151,,,3010869380,2521267781,2960545122,2961976047,84192,SRX27217640,SRS23666642,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32664,SRR31857865,SRX27217639,SRS23666643,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,hars+7,,strain:TAB 5|isolate:homozygous|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,hars+7 homo 3dpf,H8,H8,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H8_S10_R1_001.fastq.gz H8_S10_R2_001.fastq.gz,fastq fastq,11762111176.0,38947388.0,H8 S10 R1 001.fastq.gz,0:151 1:151,A:3158191637;C:2650086743;G:2837081006;T:3116664980;N:86810,151,151,,,3158191637,2650086743,2837081006,3116664980,86810,SRX27217639,SRS23666643,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32665,SRR31857866,SRX27217638,SRS23666643,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,hars+7,,strain:TAB 5|isolate:homozygous|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,hars+7 homo 3dpf,H7,H7,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H7_S9_R1_001.fastq.gz H7_S9_R2_001.fastq.gz,fastq fastq,11201951006.0,37092553.0,H7 S9 R1 001.fastq.gz,0:151 1:151,A:2996334808;C:2532313612;G:2716221063;T:2956997482;N:84041,151,151,,,2996334808,2532313612,2716221063,2956997482,84041,SRX27217638,SRS23666643,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32666,SRR31857867,SRX27217637,SRS23666643,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,hars+7,,strain:TAB 5|isolate:homozygous|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,hars+7 homo 3dpf,H6,H6,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H6_S8_R1_001.fastq.gz H6_S8_R2_001.fastq.gz,fastq fastq,11325762852.0,37502526.0,H6 S8 R1 001.fastq.gz,0:151 1:151,A:3046271836;C:2547878695;G:2731260927;T:3000266485;N:84909,151,151,,,3046271836,2547878695,2731260927,3000266485,84909,SRX27217637,SRS23666643,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32667,SRR31857868,SRX27217636,SRS23666643,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,hars+7,,strain:TAB 5|isolate:homozygous|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,hars+7 homo 3dpf,H5,H5,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H5_S7_R1_001.fastq.gz H5_S7_R2_001.fastq.gz,fastq fastq,10652265102.0,35272401.0,H5 S7 R1 001.fastq.gz,0:151 1:151,A:2905304604;C:2361430452;G:2529712525;T:2855737029;N:80492,151,151,,,2905304604,2361430452,2529712525,2855737029,80492,SRX27217636,SRS23666643,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32668,SRR31857869,SRX27217635,SRS23666641,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,WT,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,TAB5 3dpf,H4,H4,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H4_S6_R1_001.fastq.gz H4_S6_R2_001.fastq.gz,fastq fastq,12571004586.0,41625843.0,H4 S6 R1 001.fastq.gz,0:151 1:151,A:3381341743;C:2824189848;G:3028332660;T:3337047324;N:93011,151,151,,,3381341743,2824189848,3028332660,3337047324,93011,SRX27217635,SRS23666641,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures 32669,SRR31857870,SRX27217634,SRS23666641,SRP513561,PRJNA1123309,Interrogating Disease Gene Function,PRJNA1123309,Other,Genes and genetic variants associated with human disease are continually being discovered but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation F0 knockouts but these approaches are not amenable to high throughput genetic screening due to high variability cost and low phenotype penetrance.,,,,,WT,,strain:TAB 5|isolate:WT|age:3dpf|collection date:2020 11 10|geo loc name:USA: Oklahoma City|sex:unknown|tissue:Whole fish|BioSampleModel:Model organism or animal,,,,,,,,,TAB5 3dpf,H3,H3,adapter,,,RNA-Seq,TRANSCRIPTOMIC,Oligo-dT,PAIRED,ILLUMINA,Illumina NovaSeq X Plus,,SRP513561,,,H3_S5_R1_001.fastq.gz H3_S5_R2_001.fastq.gz,fastq fastq,11422119576.0,37821588.0,H3 S5 R1 001.fastq.gz,0:151 1:151,A:3065574720;C:2574277345;G:2759844042;T:3022337192;N:86277,151,151,,,3065574720,2574277345,2759844042,3022337192,86277,SRX27217634,SRS23666641,SRA2042839,Oklahoma Medical Research Foundation|Genes & Human Disease Research Program,Oklahoma Medical Research Foundation,,,,,,,,,,,,B,B,biological fallback assumption,illumina,novaseq_era,unknown,poly_a,unknown,bulk,unknown,unknown,,United States,2024-12-30,Larval,Larval,Whole Organism,All anatomical structures